Neuropace, Inc. NPCE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $15.63M-28.3% | $21.81M+5.0% | $20.77M-9.6% | $22.98M-15.3% | $27.14M+100% | ||
| $39.2M-0.4% | $39.37M0.0% | $39.37M+0.2% | $39.28M+0.1% | $39.24M-0.2% | ||
| $14.79M+0.7% | $14.68M-1.7% | $14.94M+10.2% | $13.55M-12.2% | $15.44M+20.1% | ||
| $16.69M-1.2% | $16.9M-6.8% | $18.14M+10.9% | $16.35M+20.4% | $13.58M+1.5% | ||
| $86.98M-7.5% | $94.07M-1.3% | $95.33M+1.7% | $93.74M-3.8% | $97.48M+19.8% | ||
| $1.28M+14.0% | $1.13M+1.5% | $1.11M-4.2% | $1.16M-0.3% | $1.16M+10.3% | ||
| $98.9M-6.3% | $105.57M-1.6% | $107.26M+1.1% | $106.11M-3.7% | $110.21M+16.4% | ||
| $4.51M+104% | $2.22M-51.7% | $4.59M-2.8% | $4.72M+16.7% | $4.05M+37.0% | ||
| $126K-10.6% | $141K-78.3% | $649K-6.8% | $696K+2.4% | $680K+22.5% | ||
| $16.17M-9.2% | $17.81M-9.1% | $19.61M+14.4% | $17.14M+16.6% | $14.71M-3.0% | ||
| $59.02M+0.2% | $58.88M+0.2% | $58.75M+0.2% | $58.62M-2.0% | $59.79M+0.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$559.1M-1.2% | -$552.42M-0.5% | -$549.69M-0.6% | -$546.19M-1.6% | -$537.54M-1.2% | ||
| $14.45M-24.1% | $19.03M+2.8% | $18.52M-4.7% | $19.44M-19.9% | $24.27M+203% | ||
| $98.9M-6.3% | $105.57M-1.6% | $107.26M+1.1% | $106.11M-3.7% | $110.21M+16.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuropace, Inc.'s total assets?
- Neuropace, Inc. (NPCE) holds $98.9M in total assets, down 10.3% year over year.
- How much debt does Neuropace, Inc. have?
- Neuropace, Inc. carries $70.5M in total debt against $14.5M of shareholders' equity, a debt-to-equity ratio of 4.87.
- How much cash does Neuropace, Inc. have?
- Neuropace, Inc. holds $15.6M in cash and equivalents.
- Can Neuropace, Inc. cover its short-term obligations?
- Its current ratio is 5.38 — current assets exceed current liabilities.
- Where does Neuropace, Inc.'s balance sheet data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
